BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH
1345 results:

  • 1. Abnormal expression of LCA and CD43 in SCLC: a rare case report and brief literature review.
    Cai Z; Zuo L; Hu F; You H; Lu X; Liao S; Liu F; Li L; Huang W
    BMC Pulm Med; 2024 Apr; 24(1):195. PubMed ID: 38649942
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparative study of imaging and pathology of primary mucinous adenocarcinoma with different imaging manifestations.
    Han J; Gao J; Chen D; Du M; Wu Y; Ma X; Xie M; Han H; Wu C; Xue X
    Clin Respir J; 2024 Apr; 18(4):e13750. PubMed ID: 38616354
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Health and Economic Value of Eliminating Socioeconomic Disparities in US Youth Physical Activity.
    Powell-Wiley TM; Martinez MF; Heneghan J; Weatherwax C; Osei Baah F; Velmurugan K; Chin KL; Ayers C; Cintron MA; Ortiz-Whittingham LR; Sandler D; Sharda S; Whitley M; Bartsch SM; O'Shea KJ; Tsintsifas A; Dibbs A; Scannell SA; Lee BY
    JAMA Health Forum; 2024 Mar; 5(3):e240088. PubMed ID: 38488779
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Disease control in patients with non-small cell lung cancer using pemetrexed: Investigating the best treatment strategy.
    Takahara Y; Abe R; Sumito N; Tanaka T; Ishige Y; Shionoya I; Yamamura K; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T
    Thorac Cancer; 2024 Apr; 15(12):987-993. PubMed ID: 38485287
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Biphenotypic lung carcinoma with coexpression of ttf-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature.
    Marando A; Zagni M; Negrelli M; Valtorta E; Lauricella C; Motta V; Veronese S; Cerea G; Giannetta LG; Ciarlo G; Signorelli D; Pizzutilo EG; Bonoldi E; Pelosi G
    Pathologica; 2024 Feb; 116(1):13-21. PubMed ID: 38482671
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Non-small cell lung carcinoma with focal coexpression of thyroid transcription factor-1 and Δ Np63/p40: A case report.
    Terada K; Menju T; Date H; Haga H; Yoshizawa A
    Thorac Cancer; 2024 Apr; 15(12):1029-1033. PubMed ID: 38478955
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study.
    Cezard GI; Denholm RE; Knight R; Wei Y; Teece L; Toms R; Forbes HJ; Walker AJ; Fisher L; Massey J; Hopcroft LEM; Horne EMF; Taylor K; Palmer T; Arab MA; Cuitun Coronado JI; Ip SHY; Davy S; Dillingham I; Bacon S; Mehrkar A; Morton CE; Greaves F; Hyams C; Davey Smith G; Macleod J; Chaturvedi N; Goldacre B; Whiteley WN; Wood AM; Sterne JAC; Walker V;
    Nat Commun; 2024 Mar; 15(1):2173. PubMed ID: 38467603
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of Nutritional Indices With Adverse Effects and Time-to-Treatment-Failure in Triple Therapy for lung cancer.
    Hashino Y; Matushita T; Hatsuyama T; Wakamoto A; Goto K; Hoshi T; Iwayama K; Ohtaki K; Toda T; Sato H
    In Vivo; 2024; 38(2):864-872. PubMed ID: 38418111
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers.
    Akita T; Ariyasu R; Kakuto S; Miyadera K; Kiritani A; Tsugitomi R; Amino Y; Uchibori K; Kitazono S; Yanagitani N; Tasaka S; Nishio M
    Thorac Cancer; 2024 Apr; 15(10):788-796. PubMed ID: 38400801
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficacy of immune checkpoint inhibitors in SMARCA4-deficient and TP53 mutant undifferentiated lung cancer.
    Chen J; Zheng Q; Wang J; Zhang X; Lv Y
    Medicine (Baltimore); 2024 Feb; 103(8):e36959. PubMed ID: 38394494
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
    Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
    BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study.
    Cheng WC; Lin CC; Liao WC; Lin YC; Chen CH; Chen HJ; Tu CY; Hsia TC
    BMC Cancer; 2024 Feb; 24(1):228. PubMed ID: 38373960
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Influence of
    Naqash AR; Floudas CS; Aber E; Maoz A; Nassar AH; Adib E; Choucair K; Xiu J; Baca Y; Ricciuti B; Alessi JV; Awad MM; Kim C; Judd J; Raez LE; Lopes G; Nieva JJ; Borghaei H; Takebe N; Ma PC; Halmos B; Kwiatkowski DJ; Liu SV; Mamdani H
    JCO Precis Oncol; 2024 Feb; 8():e2300371. PubMed ID: 38330261
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam.
    Pham CP; Nguyen TTH; Do AT; Nguyen TK; Hoang TAT; Le TA; Vuong DTH; Nguyen DNT; Dang VK; Nguyen TO; Pham VL; Nguyen MH; Vo THT; Do HK; Vu HT; Nguyen TTH; Pham VT; Trinh LH; Nguyen KD; Nguyen HG; Truong CM; Pham TMC; Nguyen TBP
    BMC Cancer; 2024 Feb; 24(1):176. PubMed ID: 38317094
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Discrepancies Between Morphological and Immunohistochemical Classifications Are Associated With Prognoses and Subtypes of lung cancer.
    Natsume K; Ye J; Mukai Y; Yamakawa K; Tanimoto M; Ito H; Miyagi Y; Daigo Y; Muto-Ishizuka M; Kadota K; Haba R; Suizu F
    Anticancer Res; 2024 Feb; 44(2):711-722. PubMed ID: 38307593
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Lack of imbalance between the master regulators ttf1/NKX2-1 and ΔNp63/p40 implies adverse prognosis in non-small cell lung cancer.
    Vescio M; Bulloni M; Pelosi G; Pattini L
    Sci Rep; 2024 Jan; 14(1):2467. PubMed ID: 38291083
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [A Case of Resection of T2N0 Colon cancer with Synchronous Solitary lung Metastasis].
    Shirai Y; Oshima Y; Ito S; Suzuki M; Fukasawa M; Ishikawa K; Machimura T; Nohara M; Murayama A; Sanada K; Kamochi J; Ikoma Y; Kato Y; Sakata S
    Gan To Kagaku Ryoho; 2024 Jan; 51(1):63-65. PubMed ID: 38247094
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Efficacy of osimertinib in patients with EGFR-mutation positive non-small cell lung cancer with malignant pleural effusion.
    Kiritani A; Amino Y; Uchibori K; Akita T; Harutani Y; Ogusu S; Tsugitomi R; Manabe R; Ariyasu R; Kitazono S; Yanagitani N; Nishio M
    Thorac Cancer; 2024 Feb; 15(5):402-409. PubMed ID: 38226415
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. "All in one" nanoprobe Au-ttf-1 for target FL/CT bioimaging, machine learning technology and imaging-guided photothermal therapy against lung adenocarcinoma.
    Yang Z; Zhang Y; Tang L; Yang X; Song L; Shen C; Zvyagin AV; Li Y; Yang B; Lin Q
    J Nanobiotechnology; 2024 Jan; 22(1):22. PubMed ID: 38184620
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.
    Li Y; Lv X; Chen C; Yu R; Wang B; Wang D; Hou D
    Eur Radiol Exp; 2024 Jan; 8(1):2. PubMed ID: 38169047
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 68.